Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design. (2019)
Attributed to:
A randomized controlled trial of influenza vaccine to prevent adverse vascular events.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ahj.2019.02.009
PubMed Identifier: 30933856
Publication URI: http://europepmc.org/abstract/MED/30933856
Type: Journal Article/Review
Volume: 212
Parent Publication: American heart journal
ISSN: 0002-8703